Discordance between CSF amyloid beta and PET‐derived amyloid status and its clinical implications

Abstract

Background: There has been a recent focus within Alzheimer's Disease (AD) research on potential CSF biomarkers as diagnostic tools. PET imaging and CSF biomarkers have been used to determine the amyloid status of individuals when characterising AD.

The paper